Clinical Practice Guidelines

Administration of Blood and Blood Products

• Coagulation Reference Binder
• Elements of Informed Consent for Blood and Blood Products
• Guide to Blood Component and Blood Product Administration

Adverse Event Reporting

• Algorithm for Transfusion Reactions
• Investigation of Adverse Transfusion Reactions
• Provincial Reporting Process for Adverse Reactions

Blood and Blood Products

• Albumin
  • Albumin Administration Guildelines 
• C1 Esterase Inhibitors
  • Product Administration Guidelines Berinert
  • Product Administration Guidelines Cinryze
• Components
  • Nova Scotia Guideline for Blood Component Utilization in Adults and Pediatrics
  • NSHA CL-BP-010 Irradiated Blood
• Dabigatran and Rivaroxaban
  • Managing Bleeding
  • Blood Guidelines Reference List​
• Factor Product Sheets
  • Product Administration Guidelines ADYNOVATE
  • Product Administration Guidelines ALPROLIX
  • Product Administration Guidelines BeneFIX
  • Product Administration Guidelines Corifact
  • Product Administration Guidelines Eloctate
  • Product Administration Guidelines FIBRYGA
  • Product Administration Guidelines Feiba NF  
  • Product Administration Guidelines Humate-P
  • Product Administration Guidelines Kovaltry
  • Product Administration Guidelines NiaStase RT
  • Product Administration Guidelines Nuwiq
  • Product Administration Guidelines REBINYN
  • Product Administration Guidelines RiaSTAP
  • Product Administration Guidelines Wilate
  • Product Administration Guidelines Xyntha and Xyntha Solofuse   
•  Heme
  • Product Administration Guidelines PANHEMATIN

Immunoglobulins

• Memorandum: Atlantic Ministries of Health Common Policy for the Utilization of Intravenous and Subcutaneous Immunoglobulins
• Atlantic Ministries of Health Common Policy for the Use of Intravenous and Subcutaneous Immunoglobulin
• Atlantic Clinical Indications and Criteria for Intravenous and Subcutaneous Immunoglobulin (IVIG/SCIG) Version 1.0

• Intravenous Immunoglobulin (IVIG)
  • Adjusted Body Weight Calculator with IVIG Dosing for Adults
  • Product Administration Guidelines  Intravenous Immune Globulins (IVIG) – Both Adult and Pediatric
  • Cytogam Infusion Rate Table
  • Cytogam® Administration Guidelines 
  • Gammagard Liquid Infusion Rate Table
  • Gammagard SD Infusion Rate Table
  • Gamunex-IGIVnex Infusion Rate Table
  • Privigen Infusion Table
• Subcutaneous Immunoglobulin (SCIG)
  • Addendum to the Atlantic Guidelines for Subcutaneous Immunoglobulin (SCIG) Home Administration Programs
  • Atlantic Guidelines for Subcutaneous Immune Globulin Home Administration Programs
  • Curvitru Administration Guide
  • National Advisory Committee (NAC) Recommendations for SCIG
• Immunoglobulin – Other
  • Product Administration Guidelines - GamaSTAN 
  • Product Administration Guidelines – HyperHEP B S/D
  • Product Administration Guidelines - VariZIG 
  • Product Administration Guidelines - WinRho
• Massive Transfusion
  • Guideline for the Appropriate Use of Blood Components/Products
  • Massive Transfusion Algorithm
  • User’s Guide for the Massive Bleeding Data Collection Form
• Prothrombin Complex Concentrates (Octaplex and BeriplexP/N) The NSPBCP does not endorse any one product
  • Product Administration Guidelines - Beriplex
  • Product Administration Guidelines - Octaplex
  • National Advisory Committee (NAC) Recommendations for Use of Prothrombin Complex Concentrates in Canada
  • Prothrombin Complex Concentrate Reconstitution Guide (YouTube Video)
  • Nova Scotia Guideline for the Management of Patients on Vitamin K Antagonists or Direct Oral Anticoagulants Utilizing Prothrombin Complex Concentrates
• Rh Testing
  • Guideline for Rh Testing in Nova Scotia
  • Laboratory Pre-Natal RhD Typing Flowchart
  • Laboratory Rh Typing Flowchart – All Samples Except Pre-Natal
• S/D Plasma
  • Administration Guidelines Octaplasma (S/D Treated Human Plasma)
  • Framework for Appropriate Use and Distribution of Solvent Detergent Treated Plasma in Canada
• Blood Emergency Preparedness
• The Provincial Blood Contingency Plan
• National Plan for the Management of Shortages of labile Blood Components
• Emergency framework for rationing of blood for massively bleeding patients during a red phase of a blood shortage

Recipient Recall Notification

• NAC Recommendations for the Notification of Recipients of a Blood Component Recall